Inhibition of EGFR leading to prevention of fibrosis in high fat diets demonstrates how EGFR could be a nexus that distinguishes asymptomatic steatosis from one that progresses into liver fibrosis. The gene discussed is EGFR; the disease is Hepatic fibrosis.